glp-1 gastric stasis attorney in louisiana semaglutide lawyer west virginia gastroparesis in west virginia Gastroparesis Lawsuit louisiana semaglutide gastric stasis attorney

DOI: 10.1038/s41419-017-0217-y [Google Scholar] Zhang X, Jiang J, Xu J, Chen J, Gu Y, Wu G

Key drivers behind GLP-1 and addiction research include: Rapid expansion in the use of GLP-1 medications such as semaglutide (Ozempic and Wegovy) and tirzepatide (Maunjaro and Zepbound) Reports of changes in cravings, alcohol use, or reward-seeking behaviors beyond weight loss Increased public conversation and clinical curiosity about psychological and behavioral effects Scientific interest in GLP-1 activity within reward pathways and dopamine signaling Recognition that appetite regulation and addiction involve shared neural mechanisms This research is still emerging, and findings should be interpreted with caution

It has also been shown to delay gastric emptying and help suppress appetite

But are the potential side effects worth it

Will I always feel full and never want to eat on GLP-1 medications

Why Is Mounjaro More Effective